Scilex Holding (SCLXW) Total Current Liabilities (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Total Current Liabilities of $501.8 million in Q1 2026, up 3.74% quarter-over-quarter from $483.7 million in Q4 2025, and up 81.96% on a YoY basis from $275.7 million in Q1 2025.

Scilex Holding (SCLXW) Total Current Liabilities (2020 - 2026) Analysis & Trends

Scilex Holding's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $501.8 million for Q1 2026.

  • In Q1 2026, Total Current Liabilities rose 81.96% year-over-year to $501.8 million; the TTM figure through Mar 2026 stood at $501.8 million (up 81.96% YoY), while the FY2025 annual figure was $483.7 million, up 86.28% from the prior year.
  • Total Current Liabilities was $501.8 million for Q1 2026 at Scilex Holding, up from $483.7 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $501.8 million in Q1 2026 to a low of $41003.0 in Q1 2022.
  • Historically, Total Current Liabilities has averaged $215.8 million across 5 years, with a median of $252.7 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Total Current Liabilities slumped 73.53% in 2022, then surged 157454.33% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $44.8 million in 2022, then jumped by 458.36% to $250.4 million in 2023, then climbed by 3.7% to $259.6 million in 2024, then soared by 86.28% to $483.7 million in 2025, then rose by 3.74% to $501.8 million in 2026.
  • The last three Total Current Liabilities figures came in at $501.8 million (Q1 2026), $483.7 million (Q4 2025), and $358.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -30.24 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 36.63 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 57.72 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 42.10 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 26.95 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 24.96 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 9.48 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 34.35 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 19.16 Bn
10 Scilex Holding - - 4.15 Mn 501.75 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 501.75 Mn
Dec 31, 2025 483.65 Mn
Sep 30, 2025 358.95 Mn
Jun 30, 2025 305.93 Mn
Mar 31, 2025 275.74 Mn
Dec 31, 2024 259.64 Mn
Sep 30, 2024 281.54 Mn
Jun 30, 2024 255.45 Mn
Mar 31, 2024 252.73 Mn
Dec 31, 2023 250.38 Mn
Sep 30, 2023 228.58 Mn
Jun 30, 2023 103.58 Mn
Mar 31, 2023 64.60 Mn
Dec 31, 2022 44.84 Mn
Sep 30, 2022 809,292.00
Jun 30, 2022 598,646.00
Mar 31, 2022 41,003.00
Dec 31, 2021 169.42 Mn
Sep 30, 2021 43,569.00
Jun 30, 2021 20,025.00